Annual Total Long Term Liabilities
$1.31 M
$0.000.00%
December 31, 2023
Summary
- As of February 26, 2025, APRE annual total long term liabilities is $1.31 million, unchanged on December 31, 2023.
- During the last 3 years, APRE annual total long term liabilities has risen by +$1.23 million (+1563.83%).
- APRE annual total long term liabilities is now -98.84% below its all-time high of $112.59 million, reached on December 31, 2018.
Performance
APRE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.31 M
$0.000.00%
September 30, 2024
Summary
- As of February 26, 2025, APRE quarterly total long term liabilities is $1.31 million, unchanged on September 30, 2024.
- Over the past year, APRE quarterly long term liabilities has stayed the same.
- APRE quarterly long term liabilities is now -98.89% below its all-time high of $118.55 million, reached on September 30, 2019.
Performance
APRE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
APRE Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | 0.0% | 0.0% |
| 3 y3 years | +1563.8% | +4299.7% |
| 5 y5 years | -98.8% | -98.9% |
APRE Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -98.1% | -100.0% |
| 5 y | 5-year | at high | -100.0% | -98.1% | -100.0% |
| alltime | all time | -98.8% | -100.0% | -98.9% | -100.0% |
Aprea Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.31 M(0.0%) |
| Jun 2024 | - | $1.31 M(0.0%) |
| Mar 2024 | - | $1.31 M(0.0%) |
| Dec 2023 | $1.31 M(0.0%) | $1.31 M(0.0%) |
| Sep 2023 | - | $1.31 M(0.0%) |
| Jun 2023 | - | $1.31 M(0.0%) |
| Mar 2023 | - | $1.31 M(0.0%) |
| Dec 2022 | $1.31 M(>+9900.0%) | $1.31 M(-56.3%) |
| Sep 2022 | - | $3.00 M(-95.6%) |
| Jun 2022 | - | $68.78 M(>+9900.0%) |
| Mar 2022 | - | $28.10 K(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00(-100.0%) |
| Sep 2021 | - | $29.80 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $0.00(-100.0%) |
| Mar 2021 | - | $33.80 K(-57.1%) |
| Dec 2020 | $78.80 K(-74.0%) | $78.80 K(-40.7%) |
| Sep 2020 | - | $132.80 K(-28.6%) |
| Jun 2020 | - | $185.90 K(-18.2%) |
| Mar 2020 | - | $227.30 K(-24.9%) |
| Dec 2019 | $302.60 K(-99.7%) | $302.60 K(-99.7%) |
| Sep 2019 | - | $118.55 M(>+9900.0%) |
| Jun 2019 | - | $181.90 K(-99.8%) |
| Dec 2018 | $112.59 M(+100.2%) | $112.59 M |
| Dec 2017 | $56.23 M(+6925.6%) | - |
| Jun 2008 | $800.30 K(+67.1%) | - |
| Jun 2007 | $478.90 K(+441.7%) | - |
| Jun 2006 | $88.40 K | - |
FAQ
- What is Aprea Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aprea Therapeutics?
- What is Aprea Therapeutics annual total long term liabilities year-on-year change?
- What is Aprea Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly long term liabilities year-on-year change?
What is Aprea Therapeutics annual total long term liabilities?
The current annual total long term liabilities of APRE is $1.31 M
What is the all time high annual total long term liabilities for Aprea Therapeutics?
Aprea Therapeutics all-time high annual total long term liabilities is $112.59 M
What is Aprea Therapeutics annual total long term liabilities year-on-year change?
Over the past year, APRE annual total long term liabilities has changed by $0.00 (0.00%)
What is Aprea Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of APRE is $1.31 M
What is the all time high quarterly long term liabilities for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly total long term liabilities is $118.55 M
What is Aprea Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, APRE quarterly total long term liabilities has changed by $0.00 (0.00%)